April 8, 2026 STAT+: Influential Democratic think tank pushes plan for government to lower health care costs April 8, 2026 STAT+: Steve Ubl to step down as CEO of PhRMA April 8, 2026 Smart contact lens monitors eye pressure and delivers glaucoma drugs in early tests April 8, 2026 Jefferson Health sues Aetna over Medicare Advantage ‘downcoding’ policy April 8, 2026 STAT+: Terns’ drug may not be as competitive as many initially thought April 8, 2026 ICHRAs, a growth opportunity for insurers, face uphill battle April 8, 2026 STAT+: 23andMe finds genetic changes appear to help predict response to GLP-1 drugs for weight loss April 8, 2026 STAT+: Are AI scribes actually driving higher health care costs? April 8, 2026 STAT+: Pharmalittle: We’re reading about FDA seeking new powers over DTC ads, an EU pledge to fight AMR, and more April 8, 2026 Digital health funding concentrates in fewer startups: report April 8, 2026 What does MAHA look like these days? April 8, 2026 STAT+: Everyone agrees AI scribes are increasing health care costs. No one agrees what to do about it April 8, 2026 Opinion: What American hospitals can learn from India about waste April 8, 2026 STAT+: A decade ago, these drugs tore apart the FDA. Today, they might be some patients’ best hope April 8, 2026 Opinion: How sports betting is hooking some young men April 7, 2026 Judge refuses to block sending abortion pill by mail for now, but says FDA must finish review April 7, 2026 Insurers committed to cutting prior authorizations have eliminated 11% so far April 7, 2026 STAT+: Novo Nordisk launches high-dose Wegovy April 7, 2026 STAT+: Trump budget’s ‘America First’ drug policy proposals April 7, 2026 STAT+: States looking to regulate use of chatbots April 7, 2026 Veradigm names CFO as it works to get current on financial filings April 7, 2026 STAT+: Many cancer patients don’t get genomic tests to guide treatment, study finds April 7, 2026 CMS finalizes higher Medicare Advantage rates for 2027 in gift to insurers April 7, 2026 STAT+: Pharmalittle: We’re reading about FDA backing domestic production, another Gilead deal, and more April 7, 2026 STAT+: Gilead to buy cancer biotech Tubulis for more than $3 billion April 7, 2026 If you cap insulin at $35 a month, people with type 2 diabetes stick to treatment, study finds April 7, 2026 STAT+: Merck’s experimental HIV prevention pill could be made for less than $5 a year, researchers say April 7, 2026 STAT+: University of Michigan wins 2026 STAT Madness for new insights into abdominal aortic aneurysms April 7, 2026 STAT+: Research revealing how the brain flushes waste named STAT Madness Editors’ Pick April 7, 2026 STAT+: FDA backs proposals to entice pharma companies to test, make drugs domestically April 7, 2026 A star scientist showed that better genetics lessons could reduce racism. It was the death knell for his career April 7, 2026 Opinion: STAT+: Former Geisinger CEO: U.S. health systems must replace huge numbers of people with AI April 7, 2026 Opinion: How the insurance system quietly undoes recovery from addiction April 7, 2026 Standing up to Rising Prescription Drug Costs Increases Access to Breakthrough Medications April 7, 2026 STAT+: Biotech investors’ plea to Trump, and a busy M&A week April 6, 2026 STAT+: Health insurers score major win with higher 2027 Medicare Advantage rates April 6, 2026 STAT+: Pharma companies and patient groups seek to exempt orphan drugs from Colorado pricing limits April 6, 2026 STAT+: A key Medicare Advantage announcement is due today April 6, 2026 Centene creates two new executive leadership roles April 6, 2026 STAT+: Pharmalittle: We’re reading about an FDA delay forcing a biotech to close, a Neurocrine deal, and more Previous Page 1 2 3 4 5 6 7 Next Page 2026-03-30
